Misoprostol

"Misoprostol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A synthetic analog of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. It is an effective anti-ulcer agent and also has oxytocic properties.

Descriptor ID	D016595
MeSH Number(s)	D10.251.355.255.550.775.450.500 D23.469.050.175.725.775.450.500 D23.469.700.660.500
Concept/Terms	Misoprostol Misoprostol Novo-Misoprostol Novo-Misoprostol Novo Misoprostol SC-29333 SC-29333 SC 29333 SC29333 SC-30249 SC-30249 SC 30249 SC30249 Apo-Misoprostol Apo-Misoprostol Apo Misoprostol Misoprostol, (11beta,13E,16R)-Isomer Misoprostol, (11beta,13E,16R)-Isomer Glefos Glefos Misoprostol, (11alpha,13E)-Isomer Misoprostol, (11alpha,13E)-Isomer Misoprostol, (11alpha,13E,16R)-Isomer Misoprostol, (11alpha,13E,16R)-Isomer Misoprostol, (11alpha,13Z)-(+-)-Isomer Misoprostol, (11alpha,13Z)-(+-)-Isomer Misoprostol, (11alpha.13E,16S)-Isomer Misoprostol, (11alpha.13E,16S)-Isomer Misoprostol, (11beta,13E)-(+-)-Isomer Misoprostol, (11beta,13E)-(+-)-Isomer Misoprostol, (11beta,13E,16S)-Isomer Misoprostol, (11beta,13E,16S)-Isomer Cytotec Cytotec

Below are MeSH descriptors whose meaning is more general than "Misoprostol".

Chemicals and Drugs [D]
Lipids [D10]
Fatty Acids [D10.251]
Fatty Acids, Unsaturated [D10.251.355]
Eicosanoids [D10.251.355.255]
Prostaglandins [D10.251.355.255.550]
Prostaglandins, Synthetic [D10.251.355.255.550.775]
Prostaglandins E, Synthetic [D10.251.355.255.550.775.450]
Misoprostol [D10.251.355.255.550.775.450.500]
Biological Factors [D23]
Inflammation Mediators [D23.469]
Autacoids [D23.469.050]
Eicosanoids [D23.469.050.175]
Prostaglandins [D23.469.050.175.725]
Prostaglandins, Synthetic [D23.469.050.175.725.775]
Prostaglandins E, Synthetic [D23.469.050.175.725.775.450]
Misoprostol [D23.469.050.175.725.775.450.500]
Prostaglandins, Synthetic [D23.469.700]
Prostaglandins E, Synthetic [D23.469.700.660]
Misoprostol [D23.469.700.660.500]

Below are MeSH descriptors whose meaning is related to "Misoprostol".

Below are MeSH descriptors whose meaning is more specific than "Misoprostol".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Misoprostol" by people in this website by year, and whether "Misoprostol" was a major or minor topic of these publications.

Bar chart showing 12 publications over 7 distinct years, with a maximum of 3 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2007	1	0	1
2010	0	1	1
2018	0	2	2
2019	1	1	2
2021	2	1	3
2022	1	1	2
2023	1	0	1

Below are the most recent publications written about "Misoprostol" by people in Profiles.

Koenig LR, Raymond EG, Gold M, Boraas CM, Kaneshiro B, Winikoff B, Coplon L, Upadhyay UD. Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United States. Contraception. 2023 05; 121:109962.

View in: PubMed
Pearlman Shapiro M, Dethier D, Kahili-Heede M, Kaneshiro B. No-Test Medication Abortion: A Systematic Review. Obstet Gynecol. 2023 01 01; 141(1):23-34.

View in: PubMed
Friedlander EB, Raidoo S, Soon R, Salcedo J, Davis J, Tschann M, Fontanilla T, Horiuchi W, Kaneshiro B. The experience of pain in real-time during medication abortion. Contraception. 2022 06; 110:71-75.

View in: PubMed
Kerestes C, Murayama S, Tyson J, Natavio M, Seamon E, Raidoo S, Lacar L, Bowen E, Soon R, Platais I, Kaneshiro B, Stowers P. Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models. Contraception. 2021 07; 104(1):49-53.

View in: PubMed
Chong E, Shochet T, Raymond E, Platais I, Anger HA, Raidoo S, Soon R, Grant MS, Haskell S, Tocce K, Baldwin MK, Boraas CM, Bednarek PH, Banks J, Coplon L, Thompson F, Priegue E, Winikoff B. Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic. Contraception. 2021 07; 104(1):43-48.

View in: PubMed
Raymond EG, Anger HA, Chong E, Haskell S, Grant M, Boraas C, Tocce K, Banks J, Kaneshiro B, Baldwin MK, Coplon L, Bednarek P, Shochet T, Platais I. "False positive" urine pregnancy test results after successful medication abortion. Contraception. 2021 06; 103(6):400-403.

View in: PubMed
Friedlander EB, Soon R, Salcedo J, Tschann M, Fontanilla T, Kaneshiro B. Text message link to online survey: A new highly effective method of longitudinal data collection. Contraception. 2020 04; 101(4):244-248.

View in: PubMed
Raymond E, Chong E, Winikoff B, Platais I, Mary M, Lotarevich T, Castillo PW, Kaneshiro B, Tschann M, Fontanilla T, Baldwin M, Schnyer A, Coplon L, Mathieu N, Bednarek P, Keady M, Priegue E. TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States. Contraception. 2019 09; 100(3):173-177.

View in: PubMed
Friedlander EB, Soon R, Salcedo J, Davis J, Tschann M, Kaneshiro B. Prophylactic Pregabalin to Decrease Pain During Medication Abortion: A Randomized Controlled Trial. Obstet Gynecol. 2018 09; 132(3):612-618.

View in: PubMed
Whitehouse K, Fontanilla T, Kim L, Tschann M, Soon R, Salcedo J, Kaneshiro B. Use of medications to decrease bleeding during surgical abortion: a survey of abortion providers' practices in the United States. Contraception. 2018 06; 97(6):500-503.

View in: PubMed

People

Explore

Similar Concepts

Top Journals